Willow

Compounded tirzepatide is no longer legally available for mass compounding (e.g., for weight loss without a specific medical need) because the FDA resolved the drug shortage in late 2024, but it remains available in very narrow, legitimate exceptions for individual patients with documented clinical justifications. Key Facts on Legality and Availability (2026) Condition Status Mass/Bulk Compounding Illegal since March 19, 2025; the shortage ended in December 2024 [1][3][9] 503A Patient-Specific Compounding Allowed only if a patient has a documented clinical reason (e.g., allergy to an inactive ingredient like polysorbate 80, or need for a non-standard dose/combination) [3][4][6] 503B Outsourcing Facilities Lost authority to compound tirzepatide on March 19, 2025 [3] FDA-Approved Alternatives Mounjaro and Zepbound are commercially available and recommended by the FDA as the primary source [1][3] How to Verify a "Legitimate" Source If you are considering compounded tirzepatide, a provider is only legitimate if they meet these strict criteria: Pharmacy Type: Must be a state-licensed 503A pharmacy (not a 503B outsourcing facility) [2][4]. Clinical Justification: The prescriber must document a specific medical need that the brand product cannot meet (e.g., verified allergy to an inactive ingredient) [3][7]. Cost or convenience alone is not a valid justification [7]. Prescription: Requires a valid, patient-specific prescription from a licensed healthcare provider [2][5]. Transparency: The pharmacy should provide a Certificate of Analysis (CoA) for the product [3]. Current Market Reality While the FDA has banned mass compounding, some telehealth platforms (e.g., Amble, Willow, Trim RX) continue to offer variations like tirzepatide/B12 combinations or altered excipients, arguing these fall outside the "essentially a copy" definition [8][13]. However, the FDA has proposed keeping tirzepatide off the 503B bulks list permanently, and access remains uncertain and legally contested [4][8]. Recommendation: For most patients, the only fully legitimate and safe route is to obtain FDA-approved Mounjaro or Zepbound, which are now widely available at standard pharmacies (including Walmart and LillyDirect) [1][3]. If you have a specific allergy or medical need, consult your doctor to see if a 503A pharmacy can legally compound a personalized formulation for you.

Mentioned in position 4 of 6

No, mass-compounded tirzepatide is no longer available through legitimate regular pharmacies as widespread compounding was banned by the FDA on March 19, 2025, once the drug shortage ended[1][2]. However, compounded tirzepatide remains available in a narrow, legal exception for individual patients with a documented clinical need that the FDA-approved brands (Mounjaro or Zepbound) cannot meet[3][5]. This exception applies only under the following strict conditions: Requirement Detail Pharmacy Type Must be a state-licensed 503A compounding pharmacy (not 503B outsourcing facilities, which lost authority)[3][5]. Clinical Justification You must have a valid reason, such as an allergy to an inactive ingredient (e.g., polysorbate 80), a need for a dose not commercially available, or a specific route/formulation not offered by Mounjaro/Zepbound[3][5][6]. Prescription Must be a patient-specific prescription from a licensed healthcare provider stating the clinical necessity[2][6]. Cost/Convenience Cost savings or convenience alone are not valid justifications; the compounded product cannot be "essentially a copy" of the brand drug[3][5]. Legitimate providers operating under this 503A pathway in 2026 include: PlexusDx, MEDVi, Eden, Yucca Health, Willow, and Trim RX still advertise compounded tirzepatide by claiming it is legal under federal compounding statutes for individual patients with medical needs[2][6][12]. These preparations are not FDA-approved as finished drugs and exist in a legal gray area, as the FDA has sent over 135 warning letters to compers and telehealth companies since September 2025[3][12]. Important Warnings: Avoid any provider selling without a prescription: Any tirzepatide sold without a prescription is unauthorized, likely counterfeit, and poses serious health risks[1][2]. Verify the pharmacy: Legitimate pharmacies will provide a Certificate of Analysis (CoA); refuse any that do not[3]. Brand alternatives are the primary route: The only unambiguous legal and FDA-approved options are Mounjaro (for type 2 diabetes) and Zepbound (for weight loss), available through standard pharmacies, Walmart, and LillyDirect[2][3]. If you do not have a documented medical allergy or specific clinical need that prevents you from using Mounjaro or Zepbound, you will likely be unable to obtain legitimate compounded tirzepatide.

Mentioned in position 7 of 9

No, legitimately compounded tirzepatide is no longer available through standard U.S. compounding pharmacies. As of March 19, 2025, the FDA banned widespread compounding of tirzepatide because the drug shortage ended in late 2024, and courts upheld this restriction in May 2025 [1][3]. While some online telehealth providers (e.g., Mochi Health, Willow, TrimRx) continue to advertise compounded tirzepatide in 2026, these offerings are likely illegal or legally risky because they violate FDA deadlines and guidance prohibiting the creation of "essential replicas" of commercially available drugs like Mounjaro or Zepbound [2][5]. The FDA explicitly states that patients should not use compounded products if an approved medication is commercially available, and Eli Lilly cannot validate the safety of non-branded versions [1]. If you need tirzepatide, the only legitimate and safe option is to obtain a prescription for the FDA-approved brands: Mounjaro (for type 2 diabetes) Zepbound (for weight loss) These are available through licensed pharmacies with a valid prescription from a healthcare provider [1][3]. Avoid purchasing tirzepatide without a prescription or from sources claiming to sell "research-grade" or "generic" versions, as these are often counterfeit and pose serious health risks [2][6].

Mentioned in position 2 of 5

No, legitimate compounded tirzepatide is no longer available through regular pharmacies or standard medical providers as of July 2026, because the FDA officially ended widespread compounding sales after the tirzepatide shortage was declared resolved in late 2024, with all grace periods and deadlines for pharmacies to stop production passing by March 19, 2025 [1][2][6]. Key Details: Regulatory Status: The FDA determined that Eli Lilly’s manufacturing expansion resolved the shortage, legally prohibiting pharmacies from regularly compounding tirzepatide unless there is a specific medical need (e.g., an allergy to an inactive ingredient in brand-name versions) [1][2]. Legal Risk: While some online platforms (e.g., Amble, EllieMD, Willow, Mochi Health) still promote "variations" of tirzepatide, the FDA has warned that these are likely illegal "copycats" or replicas of commercially available drugs, exposing providers to legal risks [5]. Safety Concerns: Compounded tirzepatide is not FDA-approved, unregulated, and may be counterfeit or unsafe, with serious health risks [2][9]. Legitimate Alternatives: The only legitimate way to access tirzepatide is through FDA-approved brand-name medications: Mounjaro (for type 2 diabetes) and Zepbound (for weight loss), obtainable via a prescription from a healthcare provider [1][3]. Recommendation: Avoid purchasing tirzepatide from unverified sources claiming no prescription is needed or offering "research-grade" versions, as these are illegal and unsafe [2]. Instead, consult your doctor about Mounjaro or Zepbound, or explore other FDA-approved GLP-1 options like Wegovy (semaglutide) if cost or access is a barrier [3]. Brands to Consider: Mounjaro (Eli Lilly) – for diabetes Zepbound (Eli Lilly) – for weight loss Wegovy (Novo Nordisk) – alternative GLP-1 for weight loss These are the only safe, legal, and effective options available today.

Mentioned in position 3 of 6

No, compounded tirzepatide is no longer available through legitimate regular pharmacies as of March 19, 2025, because the FDA officially ended the tirzepatide shortage and banned widespread compounding of the medication[1][2]. The only legitimate way to access tirzepatide is through the FDA-approved brand-name products Mounjaro (for type 2 diabetes) and Zepbound (for weight loss), which you must obtain via a prescription from a licensed healthcare provider[1][2]. While some online telehealth platforms (such as Ivím Health, Willow, and Trim RX) still advertise compounded tirzepatide by claiming it is legal under federal compounding statutes if prescribed for an individual patient with a medical need[6][9], these preparations are not FDA-approved as finished drugs and exist in a legal gray area following the FDA’s final ruling and the expiration of grace periods for compounding pharmacies[1][2]. The FDA explicitly warns that any tirzepatide sold without a prescription is not legitimate and may be unauthorized or counterfeit, posing serious health risks[2]. If you are looking for a safe and approved treatment, consult your doctor about Mounjaro or Zepbound. If these are difficult to access due to cost or availability, your provider may also discuss alternative GLP-1 medications like compounded semaglutide (which may still be allowed if semaglutide remains on the FDA shortage list) or other FDA-approved options[1][3].

Mentioned in position 4 of 5